FIP in the Media

January 2014

Statement Media from Members of the Malaysian Parliment on counterfeit medicinesV.Sivakumar YB Batu Gajah MP & Deputy Perak DAP on January 3, 2014 in Ipoh. (See the original version here

Counterfeit drugs are drugs that are produced and sold with the intent to defraud appearance and shape similar to the pure drug . Basically, counterfeit drugs that do not have the proper quantity of content or contain different chemicals that have absolutely nothing to do with genuine medications.

Counterfeit drugs also may not be suitable for consumption because it can have side effects or are not accepted by the body system. In addition, counterfeit drugs may contain certain chemicals that are not listed on the packaging label . At times, there pebungkusan fraud and false labeling of these drugs.

The purpose of these fake drugs in the market is to trick users and make huge profits by the manufacturers and sellers of the drugs. This thing becomes a huge problem to the producers and distributors of pure drug had to compete with synthetic drugs sold at a cheap price .

In 2003, the World Health Organisation (WHO) has estimated that the annual income derived from the sale of counterfeit drugs is more than U.S. $ 32 billion worldwide.

The existence of counterfeit drugs is an international phenomenon experienced by all countries. Malaysia is also not out of the negative symptoms . According to a study conducted by the Pharmaceutical Services Division , Ministry of Health Malaysia in 1997 found that 5.28% of framaseutikal products in the Malaysian market are counterfeit products.

In 2008, a study was conducted by Espicom ie, a pharmaceutical Asia which found that 5 % of the product Malaysia's pharmaceutical market is False. A recent survey by the Emerging Markets Health Networks in 2013 also reported that 5 % of pharmaceutical products in the Malaysian market are fake .

Is 5 % synthetic drug that is a big number ? If the question was asked to the Minister Kesihantan, the answer is obviously 'no'. For the government, 5 % of counterfeit drugs in the market is small and manageable.

In reality this number is quite large and alarming. In other words, 1 out of every 20 drugs bought were fake . This is not to be underestimated by the government. The government should take preventive measures and more effective enforcement .

In India, a country so vast with a population exceeding 1 billion people , it was found that only 3.1 % of the common medications on the market are fake. This has been confirmed by a survey study by the International Pharmaceutical Federation, a global organization representing 3 million pharmacists and pharmaceutical scientists. The percentage of synthetic drugs in India is lower than Malaysia .

The drugs often imitated or counterfeited by unscrupulous manufacturers usually are pain relievers , sexual stimulants , drugs to control allergies, eye drops and others . Usually, counterfeit drugs are medicines that can be purchased directly from drug stores without a prescription. Only drugs that are popular and in high permintaam people only copied because the profit motive.

How counterfeit medicines can enter the market ? Why is enforcement so lax in our country at all? Synthetic drugs can not cure the disease but can lead to complications more harm to the patient. Therefore, the government should have a policy to combat counterfeit medicines so that our country can achieve 'Zero Synthetic Drugs'

 The government should find ways new technology to detect artificial produk2 order to secure the safety and well-being of Malaysians . For example, the ' radio frequency identification , spectrocsopy and energy - dispersive x - ray diffraction ' is one of the methods that can be adopted to combat this menace as in developed countries . The traditional method of raids and inspections of certain products in drugstores or places of sale of drugs should also be pursued more frequently to ensure that the interests of the public.

September 2013

FIP Congress 2013 in the Media

 

Address for Minister Alex White - Symposium for Senior Pharmaceutical Policy Makers - Royal College of Physicians of Ireland - FIP Congress Dublin 2013

'Ladies and Gentlemen, I am delighted to welcome you this morning at the Royal College of Physicians of Ireland for the launch of this Symposium for international Pharmaceutical Policy Makers. It has been organised by the Irish Ministry for Health as a follow-up to the Health Ministers’ Summit which took place in Amsterdam in October 2012. That Summit examined the benefits of responsible use of medicines. At this Symposium today, we will build on this theme to discuss how to achieve responsible use of medicines. Read the full address here. Via Irish Department of Health

 

 

FIP World Congress Dublin 2013 articles published in the IPU Review in October, November and December 2013.

Click here to see them.

Pilot for Multimedia Online Training Through DialogEDU and GlobalHealth Education Significantly Improves Pharmacists' Clinical Knowledge About a New Breast Cancer Drug
 
WEST PALM BEACH, FL--(Marketwired - Sep 4, 2013) - Pharmacists at the Dana-Farber Cancer Institute evaluated a multimedia online training platform through DialogEDU to learn about a newly approved breast cancer drug, according to a poster presented at the International Pharmaceutical Federation (FIP) in Dublin. Ninety-two percent of participants preferred the online training over previous methods of learning.

Read the full note here. Via Digital Journal

Majority of pharmacy websites are non-compliant

Only 3 per cent of internet pharmacy websites are legitimate, meaning those who buy medicines online could be putting themselves at huge risk, a conference in Dublin has heard.


Research presented at the 2013 International Pharmaceutical Federation (FIP) World Congress found the overwhelming majority of websites selling medicines are operating illegally. The US National Association of Boards of Pharmacy (NABP) reviewed 10,533 pharmacy websites and found 10,181 (96.6 per cent) to be in conflict with US pharmacy laws.

Full note here. Via Irish Times.

FIP Congress: Price for Martin Schulz

Professor Martin Schulz (photo) has been awarded the FIP Distinguished Practice Award.

Full note here (in German). Via Pharmazeutische Zeitung.

The International Pharmaceutical Federation FIP awards Carmen Pena with the Fellow Award

The president of the General Council of Official Colleges of Pharmacists, Carmen Pena, has been recognized with the Fellow Award International Pharmaceutical Federation (FIP), which has received at the hands of its president, Michel Buchmann, during the Congress Opening Ceremony of FIP which is being held in Dublin between August 31 and September 5.

Full note here (in Spanish).  Via Mirada Profesional.

Congreso de la FIP: “Hacia una visión de futuro para los pacientes complejos”

Del 31 de agosto al 5 de septiembre se va a celebrar en Dublín (Irlanda) el Congreso 2013 de la Federación Internacional Farmacéutica (FIP), entidad que representa a tres millones de farmacéuticos de todo el mundo. 31 and September 5.

Full note here. Via COFM.

 

FIP publishes six recommendations to tackle medicines shortages

All countries should investigate the potential to establish a national body charged with gathering and sharing information about demand for and supply of medicines within their jurisdiction, according to a report on medicines shortages released this week (2 September 2013) at the International Pharmaceutical Federation (FIP) World Congress of Pharmacy in Dublin. This is one of six recommendations made as a result of an international summit held in Toronto in June this year.

Full note here. Via Pharmacy Journal online.

 

April 2013

Canadian pharmacists expand services, quote FIP work

MONTREAL — Quebec patients with minor ailments may soon be able replace a trip to the doctor’s office or clinic with one to the neighbourhood pharmacy.

New legislation will expand the role of Quebec pharmacists to tasks that have traditionally been reserved for doctors.

The province’s introduction of Bill 41 drew on recent amendments to pharmacy laws in other Canadian provinces aimed at easing pressure on family doctors, clinics and emergency rooms.

Pharmacists will not be able to diagnose health conditions, but they will be able to extend a prescription for one year, as well as adjust medications and order and interpret laboratory tests that monitor drug use.

Pharmacists will also be able to provide patients with drugs for the prevention of certain conditions, for example, anti-malaria, morning sickness, traveller’s diarrhea and the morning-after pill.

Proposed changes to Quebec’s pharmacy act reflect a growing perception that pharmacists are more than mere pill dispensers.

Alberta was the first province in 2005 to allow pharmacists to extend prescriptions. Quebec’s adoption of Bill 41 is consistent with the concept of “pharmaceutical care” adopted by the World Health Organization and International Pharmaceutical Federation.

Read the full story here

 

December 2012

FIP published in World Medical Journal

FIP has recently published an article entitled Regulation of Health Professions: Disparate Worldwide Approaches are a Challenge to Harmonization in the World Medical Journal. Access the full publication here.

FIP authors article for World Health Summit

FIP has recently been published in the journal for the 2012 World Health Summit with an article entitled Higher Education and a Needs Based Pharmacy Workforce. Access the full publication here.

 

October 2012

FIP mentioned in document on setting health system policies via pharmaceutical care

In a new report by the European Directorate of the Quality of Medicines & Healthcare at the Council of Europe entitled Pharmaceutical care – policies and practices for a safer, more responsible and cost-effective health system FIP is mentioned several times for work in this area.

Click here to access the online document.

 

August 2012

FIP President contributes to Prescrire

FIP President Michel Buchmann recently contributed to an article in Prescrire, August edition, 32:346, pages 606-609 (not available online) but title can be seen as ‘Pharmaciens d'officine : vision d'avenir’ [A vision of the Future for community pharmacy]

 

June 2012

FIP President contributes to article on person- and people-centred care

FIP President Michel Buchmann recently contributed to an article entitled The pharmacist’s perspective to advance person- and people-centered care. 

Click here to read the full article. 
 

May 2012

FIP Congress Director Carola van der Hoeff featured in Association Event Planner Magazine

Carola van der Hoeff, FIP's resident Congress Director, has recently been featured in Association Event Planner Magazine, highlighting her work since becoming part of the FIP team and the success of the last FIP Congress in Hyderabad, India.

Read the full story here

FIP Centennial in the German Media

Prof. Dr. Martin Schulz recently promoted the FIP Centennial in the German Pharmazeutische Zeitung. Read the full story here (German). 

 

March 2012

FIP quoted in article on medicines shortages

L'actualité.com, a French Canadian news magazine, has quoted FIP work in an article on medicines shortages. Read the full article here.

FIP noted in APhA Article on Counterfeit Medicines

The FIP website was cited in a recent article released by the American Pharmacists Association (APhA) entitled Role of the Pharmacist in Preventing Distribution of Counterfeit Medications.

Read the full article here.

PSI Launches Forum, Announces FIP Congress 2013

The Taoiseach Enda Kenny TD, with the Pharmaceutical Society of Ireland (PSI), the pharmacy regulator, has today launched new structures of education and training for pharmacists in Ireland which will oversee their continuing professional development (CPD) as well as implement a new best-practice pharmacist education system.  The PSI also announced that it had won a major international pharmaceutical congress [FIP] for Ireland to take place in 2013.

Read the full story here 

 

November 2011

FIP Diabetes Report makes headlines

BioPortfolio publishes FIP's report for World Diabetes Day - Pharmacists' contributions to diabetes care

See more here

 

October 2011

FIP President Michel Buchmann's presentation cited re counterfeit meds

The online French publication IMPACT-SANTE recently reported on FIP President Michel Buchmann's presentation on counterfeit medicines, paying special attention to the role of pharmacists in fighting this global problem.

Read the full story here

 

August 2011

‘71st FIP will enhance image of Indian pharma sector'

Persistant efforts have made it possible for the Indian host committee to bring an international event like International Pharmaceutical Federation (FIP) to India this year. Ajit Singh, Expert Member, Bureau of Pharmaceutical Sciences, FIP and chairman, ACG Worldwide shares details of his role as a committee member and the potential of the event with Usha Sharma.

Read the full story here

 

July 2011

FIP in ExpressPharma India

As the FIP Congress moves to India for the first time, Prafull D Sheth,Vice President, FIP gives Express Pharma a behind-the-scenes glimpse of the organisation behind the landmark event

Read the full story here

 

May 2011

FIP Visits China

The Chinese Pharmaceutical Association (CPA) was pleased to report a visit of FIP President Dr Michel Buchmann and FIP CEO Mr Ton Hoek.

The full report can be found on the CPA website here (translated version).

 

April 2011

Pharmacy Education Taskforce in the Lancet

The Pharmacy Education Taskforce had a letter published in the Lancet in response to an article about transforming health professional education.

Transforming health professionals' education. By - Pharmacy Education Taskforce Advisory Group

To see the full text click here

Congratulations to our Advisory Group Team!

 

 

February 2011

FIP Endorses WEF Global Health Data Charter

The World Economic Forum today launches an ambitious project to advance global health through improved data collection and management. The Global Health Data Charter recognizes that accurate health data is essential for effective and efficient health management. The Charter aims to enable individuals and patients, health professionals and policy-makers to make more informed decisions through secure access to comprehensive, quality data.

Read the full story here

 

November 2010

WHPA mobilises action against counterfeit medical products

PRIOR to its meeting in Abuja which opened Monday in Abuja, the World Health Professions Alliance, WHPA, has been urging further action against counterfeiting of medical products that puts human lives at risk and undermines the credibility of health systems.

The conference holding at the International Conference Center,is the platform through which the body is expressing its concern about the infiltration and sale of counterfeit medical products in the legitimate supply chainin Nigeria and around the world.

Read the full story here

 

April 2010

FIP Interview Featured in the Center for Global Development Newsletter

FIP CEO Mr Ton Hoek and Manager for External Partnerships Mr Xuanhao Chan were featured in an interview conducted by the Center for Global Development on drug resistance support for the DRWG's recommendation to strengthen developing country drug prescribing and dispensing practice. Read the full interview here.

 

February 2010

FIP and Pharmaceutical Sciences 2020 Commended in
Nature Reviews|Drug Discovery

FIP is extremely pleased to announce that the article published by the FIP Board of Pharmaceutical Sciences, under the authorship of Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah,
Kamal Midha and Hubert Leufkens entitled Pharmaceutical Sciences in 2020 has been featured in Nature Reviews|Drug Discovery. Click here to download the full article. Congratulations!

 

January 21 2010

FIP and the Tripartite action for Global Pharmacy Education

The site allAfrica.com mentioned FIP and its partners in Global Pharmacy Education in the article "Pharmacists Urge Creation of Food, Drugs Unit in Health Ministry", which reported that pharmacists under the [FIP Member Organisation] the Pharmaceutical Society of Nigeria "have called for the creation of Foods and Drugs Services Department (FDSD) at the Ministry of Health, charged with the responsibility of developing pharmaceutical care in teaching and specialist hospitals and Federal Medical Centres across the country".  Read the full article here.

 

January 15 2010

FIP named in the Fight Against Counterfeit Medicines

The Indian Pharmacy Portal PHARMABIZ.com mentioned the FIP-WHO project to evaluate counterfeit medicines in India. Read the full article here.

 

November 13 2009

MEPS Pictograms story in the Pharmaceutical Journal

An extensive article on the FIP Military and Emergency Pharmacy Section's  Pictogram Project has appeared online in the Pharmaceutical Journal - click here for the story!

 

October 27 2009

Pharmacy Education Taskforce - articles published

The Taskforce has had an article published in the online development magazine Health Exchange News about the country case study workshop held in Nairobi, Kenya, this summer. Check it out here

Tana Wuliji's article on pharmacy workforce migration also appeared in this issue here

 

October 21 2009

WHO-FIP Developing Pharmacy Practice, Spanish version

Click here for a Spanish article announcing the FIP-WHO Handbook on Development Pharmacy Practice

 

September 29 2009

FIP Congress in the Media!

WHO reports on Joint Symposium - click here

Special eight page section in the Pharmaceutical Journal - click here

www.lfi.is (Iceland)

 

Pharmainfo.net

JuridoBrasil.com (Brazil)

Hindu.com

Segs.com (Brazil)

Anf.pt (Here read more about an Award Winning Poster Presentation at the FIP Congress Istanbul [Portuguese])

Cofares.es (Spain)

 

September 29 2009

The Straits Times - FIP is referenced on the topic of Self Medication in an article entitled 'DIY Cures'. Read the full article here

As stated online:

DIY cures

By: June Cheong, The Straits Times

All of us 'play doctor' to ourselves, some more so than others.

You are self-medicating when you reach for that Panadol whenever you have a headache, skipping a visit to the doctor in the process.

Self-medication is the use of non-prescription medicines by people on their own initiative, according to the International Pharmaceutical Federation.

'It requires consumers to make their own decisions in selecting and using medication to relieve or treat their medical conditions,' said

Ms Lita Chew, vice-president of the Pharmaceutical Society of Singapore.

'Responsible self-medication entails recognising when self-treatment is appropriate and when a visit to the family doctor for diagnosis and treatment is necessary,' she said.

Besides saving on doctors' fees and prescriptions, people who self-medicate help take the pressure off medical services, which are often over-subscribed.

However, while many minor ailments like fungal skin infections or the common cold can be treated with medicine bought over the counter, medical professionals caution that there are limits to self-medication.

...

Click here for full article

 

September 20 2009

FIP Pharmabridge Project makes the news -click here

 

September 2 2009

As stated online at Medilexicon.com:

Global Health Professions Urge Action On H1N1 Pandemic

A call to action to prepare for an H1N1 pandemic at a country and community level has been issued by the World Health Professions Alliance.

The WHPA, a body that brings together more than 23 million health care professionals worldwide, has endorsed a set of key principles to promote operational activities that can be implemented at the country level in response to the continued spread of the H1N1 pandemic. The principles have been developed by the World Health Organization, UNICEF, the International Federation of the Red Cross and Red Crescent and the UN Office for the Coordination of Humanitarian Affairs. They reemphasize some key interventions and directly complement current World Health Organisation technical guidance and National Pandemic Influenza plans.

The Alliance, which unites dentistry, medicine, nursing, and pharmacy through their representative international organisations, the International Council of Nurses, the International Pharmaceutical Federation, the World Dental Federation and the World Medical Association, says these interventions are designed to strengthen and build on existing systems at country level and they call on all partners to integrate them into ongoing programmes.

Read full article here

 

August 3 2009

FIP President Kamal K. Midha cited for speaking at 74th Annual Conference of the Pharmaceutical Society of Ghana (PSGH), click here to link to the online article

As stated online:

Ghana to start ambitious malaria elimination programme in October

NEW. Watch live television from Ghana plus the latest Ghanaian movies plus OBE TV.
Accra, Aug. 3, GNA - The Ministry of Health (MOH) would embark on a National Malaria Elimination Programme in October, to make Ghana the first country in Africa to eliminate the disease.

Dr George Sipa- Adjah Yankey, the Sector Minister who made this known in Accra said: "I believe that this is the time for us to wage a decisive war on malaria. I have heard a number of scientists say that we cannot eradicate malaria. The difference between me and my team of scientists. is that as a Minister, I am allowed to dream and provide the leadership," he said.

The minister, who made this known at the 74th Annual Conference of the Pharmaceutical Society of Ghana (PSGH), said he was liaising with his counterparts in Nigeria, Togo, Burkina Faso, La Cote d'Ivoire and Mali to make the programme a success.

The conference on the theme: "Managing Threats and Crisis: The Vital Role of Pharmacy in an Unstable World," is a prelude to the 10th Commonwealth Pharmacists Association Conference, which takes place in Accra from August 5- August 9.

Dr Yankey said malaria was a looming crisis since resistance was slowly developing against the best arsenal, which was the artemisinin based products.

The Health Minister noted that it does not make economic sense if Ghana continue to spend more than 760 million dollars annually to combat malaria. "It is morally right if we work to save those children who loose the battle with malaria every minute," he added. Dr Yankey called for the support of pharmacists to communicate the message that would enable the public to understand their role in managing the malaria crisis.

In response to a request by Dr Alex Dodoo, President of PSGH, for government to separate the prescription and dispensation of drugs under the National Health Insurance Scheme (NHIS), the Minister announced a team, with Dr Dodoo as Chairman to streamline the situation. Dr Yankey expressed the need for health providers to view every patient as a potential source of data, saying all drug outlets are a valuable source of information "We need as a matter of urgency to put in place a system that will enable such information to be systematically captured and fed into policy."

Dr Dodoo said there was evidence that when one person provided prescribing and dispensing services within any health insurance scheme, there was the over prescribing of medicines. He contended that for several reasons dispensing doctors cost insurance schemes much more than non -dispensing doctors. "Dispensing doctors are known to prescribe more branded medicines than non-dispensing doctors; to prescribe antibiotics for simple ailments than their counterparts who do not dispense, and also to cost the health insurance scheme much more money," he said. He called on managers of the NHIS to speed up the reimbursement of pharmacies, which supply medicines and other health commodities under the scheme.

Dr Dodoo said the PSGH was also committed to the promotion of a strong and active pharmaceutical industry, geared towards wealth creation, health promotion and employment generation to ensure that Ghana became the leading centre for pharmaceutical sciences and pharmaceutical industry activities in sub-Saharan Africa. Dr Dodoo said the PSGH was counting on the support of the International Pharmaceutical Federation (FIP) to provide extensive skills, dynamic networks and global advocacy to help make the Ghanaian Pharmaceutical industry the best in Africa.

Professor Kamal Midha, President of FIP, who spoke on "Improving Public Health in Ghana; Pharmacists Role and Responsibilities," expressed concern about the flooding of the market with counterfeit drugs, which posed a threat to public health and asked pharmacists to be at the forefront to fight the menace. He stressed the need for the improvement of pharmacy education and forging of closer collaboration between the PSGH and other stakeholders to ensure effective drug administration. The PSGH conferred honorary fellowship award on Prof. Midha for his meritorious duties to the FIP, which attracts more than two million pharmacists. 

 

 

July 2009

2011 FIP Congress Announced on Pharmabiz, click here to link to the website

As stated online:

India to host prestigious 'FIP Annual Congress' in September, 2011


For the first time in its around 100-year old history, the International Pharmaceutical Federation (FIP), the 132-member global association of national associations of pharmacists and pharmaceutical scientists will be holding its annual congress in India at Hyderabad from September 1 to 8 in 2011.

The event is significant as the Indian pharmacy profession and education will get a big global exposure due to the FIP congress. It will be a good opportunity for the country to showcase its pharmacy profession and education to the world. The Indian Pharmaceutical Association (IPA) is taking the lead in organising this world event for the first time in India.

Over 3000 pharmacists, pharmaceutical scientists, academics, researches, students and press from 120 countries across the world are expected to be in the country to participate in sessions, workshops and discussions focused on pharmacy and education. IPA president Dr B Suresh said that the event will be a good opportunity for the country to showcase the progress made in the field of pharmacy profession and education to the world leaders.

Dr Suresh said that the FIP's priorities have expanded both literally and figuratively to meet the needs and expectations of the profession in expanding healthcare services and integrating emerging scientific developments in the world. Changes in pharmacy and the emergence of pharmacy practice as a cornerstone of the profession have led FIP to become globally visible for its advocacy on behalf of the role of the pharmacist in providing healthcare, while still maintaining its grounding in the pharmaceutical sciences.

Through the work of various individuals, working groups and taskforces, FIP initiates and implements numerous projects and programmes that are making a significant impact within global pharmacy practice, pharmaceutical sciences and community health.

Every year, FIP organises the World Congress of Pharmacy and Pharmaceutical Sciences, where thousands of pharmacists meet, learn, share and exchange views. Lectures, plenary sessions, poster exhibitions and section programmes, together with Council meetings and the Leadership Conference make this event the premier international event in pharmacy each year. The social side - finding new friends and greeting old ones - complements the varied Congress programme. The annual Congress also serves the young pharmacists group with specially planned sessions and workshops focussed on current issues facing this unique segment of the profession.

 

 

December 2008

Article on the FIP President Dr Kamal K Midha appeared on the pharmadanmark website on behalf of the FIP Danish Member Organisation,  http://www.fip.org/www/index.php?page=mo_im_pharmacy

Download the PDF here!

 

Taken from Destination Sante, Health News Agency

AIDS must not be allowed to mask another vital battle - that against TB
[9 December 2008 - 08:37]

AIDS must not be allowed to mask another vital battle - that against TB
Medication alone cannot conquer the AIDS pandemic, but it can achieve a great deal. Providing it's used properly!

This obvious fact was at the centre of the debates at the 8th International Conference on AIDS and Sexually Transmissible Infections (STIs) held in Dakar (Senegal). Because although observance of treatment is fundamental to success, the fact that HIV is being treated must not overshadow the need for treatment of opportunistic diseases. And at the forefront of these is tuberculosis.

As Alastair Reid of UNAIDS reminds us, tuberculosis "is the principal cause of illness and mortality among people living with HIV in Africa. And yet it can be treated and avoided...". In Dakar, in association with the Stop TB Partnership and the World Food Programme, the Agency ran sessions on the implementation of what it calls "the three ‘I's rule: Intensification of TB screening; preventive use of Isoniazide (anti-TB reference drug, ed.); and Infection control to reduce the burden of TB". An invaluable and timely reminder is that "in 2006, for example, only 22% of people affected by TB in sub-Saharan Africa were tested for infection with HIV. And less than 1% of HIV-positive patients received screening for TB..."

Once the illness has been unmasked, therapeutic observance is an absolute imperative. In this respect, the role of those in charge of town pharmacies - known in international jargon as community pharmacies- is absolutely essential. The Sidaction association in fact ran a "reinforcement session" aimed specifically at them. This reiterated the importance of the "Good Pharmaceutical Practice Guide drawn up by the International Pharmaceutical Federation (IPF) following lengthy consultation with pharmacists' professional associations across the world. Simple and locally adapted "it helps to improve all practices, from stock management, via nutritional recommendations, to advice when dispensing."

France's commitment will not be challenged by the crisis Because everything matters. "How can we identify and support patients who fail to observe treatment; how can we adapt the taking of antiretrovirals during Ramadan?" These are the questions facing pharmacists on a daily basis and their "role and importance (...) must be better recognised. They must be better integrated into proposed in-service training", Sidaction representatives point out.

Screening, promoting information, patient education, in-service training for professionals in the field ... there is no shortage of imperatives. The fight against HIV in Africa has perhaps made more headway in the last 6 years than during the previous 20 but while progress has been immense, the challenge remains considerable. And Africa will not face it alone. International support is more necessary than ever because HIV knows no boundaries. Any more than any other disease.

"Be assured that France will not abandon its substantial contribution to the World Fund - the leading contribution in terms of size in the European Union and the second largest in the world - nor its very considerable participation in UNITAID". Roselyne Bachelot-Narquin, French minister responsible for health, is leading the way in this respect. And she reminds us that in 2007 "France committed more than 364 million euros to this fight (and that there) can never be a question of abandoning these diplomatic priorities as a result of the global economic and financial crisis."

 

 

Published article in the European Journal of Hospital Pharmacy Practice, Autumn 2008

Safe internet buying of medicines - how and why pharmacists should help

Published articles in the European Journal of Hospital Pharmacy Practice, Summer 2008

The role of hospital pharmacists in counterfeit medicines

Counterfeit Medicines - it will never happen to me

Articles listed above from the European Journal of Hospital Pharmacy Practice reprinted with permission from Pharma Publishing and Media Europe

 

 


15 August 2008
Taken from Medical News Today,
http://www.medicalnewstoday.com/articles/118278.php

 

Leading Scientists To Present At Bio-International 2008 Conference, UK

Leading scientists in the fields of biopharmaceutics, bioequivalence and clinical pharmacology will meet in London from 22 to 24 October for the annual Bio-International Conference.

The event, named Bio-International 2008: Towards Improved Harmonization in Regulating Multisource Products, aims to develop a common approach for tackling complex bioequivalence issues such as interchangeability of cytotoxic, topical and respiratory drug products.

Some of the burning issues this year include the use of comparator drug products for establishing bioequivalence, and the application of the Biopharmaceutics Classification System in assessing bioequivalence of oral products. There will also be a special session highlighting bioequivalence issues in many countries and how these can be resolved with the experience gained in other parts of the world.

The conference will be preceded by a satellite workshop on 20 to 21 October, titled Special Dosage Forms - What's new with in vitro drug release?, which will focus on drug release testing and methodologies to evaluate product performance for special dosage forms. Both events are organised by the Royal Pharmaceutical Society of Great Britain (RPSGB) and the International Pharmaceutical Federation (FIP), and will be held at the RPSGB's headquarters in London. Delegates are invited to sign up for both events for a discounted combined fee.

Jayne Lawrence, the RPSGB's Chief Scientific Advisor, said: "Bio-International 2008 provides an excellent forum for discussion and development of consensus amongst pharmaceutical scientists working in the areas of biopharmaceutics, bioequivalence and clinical pharmacology.

The two events also offer good opportunities for professionals in these areas to interact and network with each other. I encourage anyone with an interest in these subjects to attend." For further details about these events, please see http://www.rpsgb.org/events or email science@rpsgb.org.

Notes:

Bio-International 2008 is presented by the Royal Pharmaceutical Society of Great Britain (RPSGB) and the International Pharmaceutical Federation (FIP) in cooperation with the American Association of Pharmaceutical Scientists (AAPS) and the European Federation for Pharmaceutical Sciences (EUFEPS).

The satellite workshop is presented by the RPSGB and the FIP Dissolution / Drug Release Special Interest Group (SIG).

18 January 2008

FDA & IFPMA Officials to Chair Anti-Counterfeiting Conference
on Interaction of Regulatory & Technological Approaches
1st Public Forum for WHO-led IMPACT Coalition: Singapore, 13-15 Feb 2008

Geneva, 17 January 2008 - The WHO-led International Medical Products Anti-Counterfeiting Taskforce (IMPACT) will hold its first public meeting in Singapore, 13-15 February 2008. The IMPACT Forum will address the theme “Combating Counterfeit Medicines: Where the Regulatory and Technology Roads Meet” and will be co-chaired by Dr. Ilisa Bernstein, Director of Pharmacy Affairs at the US Food and Drug Administration and Dr. Harvey Bale, Director General of the IFPMA.


Speaking in her capacity as Chair of the IMPACT Working Group on Regulatory Implementation, Dr. Bernstein commented: “Anti-counterfeiting technologies are evolving fast and the field is an increasingly complex one. Pharmaceutical manufacturers and regulators have an interest to keep themselves informed about developments and this IMPACT Forum should provide a handy means of doing so.”


Dr. Bale, who is also Chair of the IMPACT Technology Working Group, remarked: “Patients everywhere should benefit from new technologies designed to help protect the integrity of the pharmaceutical supply chain. Counterfeiting is a growing problem in many developing countries and their regulatory authorities should consider using appropriate technologies to verify the authenticity of medicines.”


The IMPACT Forum will feature two distinct sections. It will start with presentations on different technological solutions by provider companies and will continue with a discussion on how to make it easier for developing countries to use technology to good effect to combat counterfeit medicines. The Forum will be opened by Dr. John Lim, CEO of Singaporean Government’s regulatory body, the Health Sciences Authority (HSA), and is being co-organized by WHO, the IFPMA and the International Pharmaceutical Federation (FIP), which represents pharmacists associations worldwide.

To register for the Forum, please complete and submit the attached Registration Form. For more information about the Forum program, plus exhibition and sponsorship opportunities, please go to http://www.impactglobalforum.org/.

About the IFPMA:
The International Federation of Pharmaceutical Manufacturers & Associations is the global non-profit NGO representing the research-based pharmaceutical, biotech and vaccine sectors. Its members comprise 25 leading international companies and 46 national and regional industry associations covering developed and developing countries. The industry’s R&D pipeline contains hundreds of new medicines and vaccines being developed to address global disease threats, including cancer, heart disease, HIV/AIDS and malaria. The IFPMA Clinical Trials Portal (www.ifpma.org/clinicaltrials), the IFPMA’s Ethical Promotion online resource (www.ifpma.org/EthicalPromotion/) and its Health Partnerships information (www.ifpma.org – Developing World) help make the industry’s activities more transparent. The IFPMA strengthens patient safety by improving risk assessment of medicines and combating their counterfeiting. It also provides the secretariat for the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).
For further information, please contact:
Guy Willis
Director of Communications, IFPMA
E-mail: g.willis@ifpma.org

Tel: +41-22-338 32 00
Fax: +41-22-338 32 99
Web: www.ifpma.org

11 January 2008

FDA & IFPMA Officials to Chair Anti-Counterfeiting Conference

On Interaction of Regulatory & Technological Approaches 1st Public Forum for WHO-led IMPACT Coalition: Singapore, 13-15 Feb 2008

Geneva, 17 January 2008 - The WHO-led International Medical Products Anti-Counterfeiting Taskforce (IMPACT) will hold its first public meeting in Singapore, 13-15 February 2008. The IMPACT Forum will address the theme “Combating Counterfeit Medicines: Where the Regulatory and Technology Roads Meet” and will be co-chaired by Dr. Ilisa Bernstein, Director of Pharmacy Affairs at the US Food and Drug Administration and Dr. Harvey Bale, Director General of the IFPMA.

Speaking in her capacity as Chair of the IMPACT Working Group on Regulatory Implementation, Dr. Bernstein commented: “Anti-counterfeiting technologies are evolving fast and the field is an increasingly complex one. Pharmaceutical manufacturers and regulators have an interest to keep themselves informed about developments and this IMPACT Forum should provide a handy means of doing so.”

Dr. Bale, who is also Chair of the IMPACT Technology Working Group, remarked: “Patients everywhere should benefit from new technologies designed to help protect the integrity of the pharmaceutical supply chain.

Counterfeiting is a growing problem in many developing countries and their regulatory authorities should consider using appropriate technologies to verify the authenticity of medicines.”

The IMPACT Forum will feature two distinct sections. It will start with presentations on different technological solutions by provider companies and will continue with a discussion on how to make it easier for developing countries to use technology to good effect to combat counterfeit medicines. The Forum will be opened by Dr. John Lim, CEO of Singaporean Government’s regulatory body, the Health Sciences Authority (HSA), and is being co-organized by WHO, the IFPMA and the International Pharmaceutical Federation (FIP), which represents pharmacists associations worldwide.

To register for the Forum, please complete and submit the attached Registration Form. For more information about the Forum program, plus exhibition and sponsorship opportunities, please go to http://www.impactglobalforum.org/.

About the IFPMA:
The International Federation of Pharmaceutical Manufacturers & Associations is the global non-profit NGO representing the research-based pharmaceutical, biotech and vaccine sectors. Its members comprise 25 leading international companies and 46 national and regional industry associations covering developed and developing countries. The industry’s R&D pipeline contains hundreds of new medicines and vaccines being developed to address global disease threats, including cancer, heart disease, HIV/AIDS and malaria. The IFPMA Clinical Trials Portal (www.ifpma.org/clinicaltrials), the IFPMA’s Ethical

Promotion online resource (www.ifpma.org/EthicalPromotion/) and its Health Partnerships information (www.ifpma.org – Developing World) help make the industry’s activities more transparent. The IFPMA strengthens patient safety by improving risk assessment of medicines and combating their counterfeiting. It also provides the secretariat for the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

For further information, please contact: Guy Willis
Director of Communications, IFPMA
E-mail: g.willis@ifpma.org
Tel: +41-22-338 32 00 Fax: +41-22-338 32 99 Web: www.ifpma.org

24 April 2007

Dutch Minister of Education, Culture and Science Opens the Pharmaceutical Sciences World Congress, Amsterdam

Plasterk - “The world absolutely needs more drugs”

22-April-2007

This afternoon Dutch Minster of Education, Culture and Science, Dr Ronald Plasterk spoke to an audience of pharmaceutical scientists, researchers, academics and their peers at the Opening Ceremony of the Pharmaceutical Sciences World Congress (PSWC), which will run until Wednesday at the Amsterdam RAI Convention Center.

Hosted and organised by the International Pharmaceutical Federation (FIP), this is the third Pharmaceutical Sciences World Congress, and the first to be held within Europe. Previous years saw the event convene upon San Francisco and Kyoto in 2000 and 2004 respectively.

Dr Plasterk, himself a distinguished and accomplished molecular and developmental biologist, brought attention to the growing duty of current and future pharmaceutical scientists to meet the needs and demands of an expanding population by saying ‘The world absolutely needs new drugs. That should be the major challenge of the next generation… a challenge to spend their life and talents on. It is your and their duty to find these drugs.” He stated that more health workers must be educated in different and innovative ways to meet the future needs of healthcare.

His Excellency also touched on the necessity of Translational Medicines –a branch of medical research that attempts to more directly connect basic research to patient care – bridging the gap between the development of new knowledge, and the application of that knowledge to real global health threats.

This sentiment was echoed further on in the Ceremony by Dr David Nicholson, representing the pharmaceutical industry, when he explained the need for translational medicine and focused collaborative efforts in bringing new chemical entities and lead drugs into the pipeline, drugs that move beyond the Phase 2 Clinical Trials that are dismissing so many current prospective medicines. Dr Nicholson stressed the fact that in the US the rate of approval for new medicines has remained more or less constant over the past 20 years, further emphasized on a global level, with Europe beginning to lag behind the US in potential new drug candidates.

Dr Thomas Lönngren, Executive DIrector of EMEA, brought the regulatory perspective into view as well, and stressed the need for collaboration between regulatory, academic and industrial branches to follow common paths and work together to bring new potential medicines into the pipeline, those that will be essential to meet the healthcare demands of an expanding aging population with healthcare needs to match.

The Opening Ceremony was also a venue to showcase FIP and the Board of Pharmaceutical Sciences. FIP President Dr Kamal K Midha took to the podium to welcome all to the Congress, and before an audience of peers spoke of the test posed in tackling the global spread of disease and ill health: “In this year’s World Congress, we, the Pharmaceutical Scientists, have the opportunity and the responsibility to commit ourselves to discovering and developing approaches which directly address these global challenges…” Sentiments were also expressed by PSWC Chair Dr Daan Crommelin, who welcomed to the over 2000 participants to this event, years in the making.

The Board of Pharmaceutical Science was also extremely pleased to present the PSWC Research Achievement Awards throughout the opening ceremony, and wish to offer sincere congratulations to Dr Hiroshi Terada, Dr Kathy Giacomini, Dr Ole J. Bjerrum, Dr Hans Junginger, Dr Kevin Shakesheff, Dr William Charman, Dr Ole J. Bjerrum, Dr Hans Junginger, Dr Kevin Shakesheff and Dr William Charman. As this award denotes, the contributions of these incredible pharmaceutical scientists are shaping the future of the research and medicine, and they are most deservedly granted.

The PSWC 2007 will continue throughout Wednesday 25 April – FIP looks forward to bringing news all events and outcomes.

19 April 2007

WORLD’S LEADING PHARMACEUTICAL SCIENTISTS MEET FOR THE FIRST TIME IN EUROPE

Over 2500 scientists, researchers and academics will soon be welcomed by the Board of Pharmaceutical Practice of the International Pharmaceutical Federation (FIP), the hosts of the Pharmaceutical Sciences World Congress 2007 in Amsterdam. All will convene to take in lectures, workshops, satellite symposia and poster presentations, all in total numbering over 1000, making the PSWC the biggest and most significant global event in the field.

This year, the central theme of the PSWC is “Optimising Drug Therapy: An Imperative for World Health”. Speakers include some of the world’s leaders in pharmaceutical science and world health, such as Dr Thomas Lundgren, Chief of the European Agency for the Evaluation of Medicinal Products and Dr Richard Laing from the World Health Organization. Further to this, the PSWC will investigate the latest innovations steering the pharmaceutical and therapeutic disciplines with sessions on pharmacogenetics, individualized medicine, “omics” technologies, patient compliance, quality of medicines and counterfeiting, post marketing surveillance programmes and a satellite workshop on monoclonal antibodies, to name just a few.

The PSWC Opening Ceremony will play host to Dr Ronald Plasterk, Minister of Education, Culture and Science of the Netherlands and renowned scientist in his own right. It is an honour and privilege to welcome Dr Plasterk to the event, and hope all will join in this momentous occasion.

Organised by the FIP Board of Pharmaceutical Sciences with such partners as the European Federation for Pharmaceutical Sciences (EUFEPS) this world-class event happens just once every 3-4 years and welcomes the most influential and prestigious scientists, researchers and academics to discuss the most current and groundbreaking innovations steering the pharmaceutical sciences.

For more information on the PSWC as well full access to the Final Programme and all submitted abstracts, please visit www.fip.org/pswc

More information »